Analyst says Apollo Hospitals overvalued but wait for pullback
Apollo Hospitals surged after announcing a spin-off of its pharmacy and digital health arms. However, analyst Akhilesh Jat flagged its high P/E ratio of 72, which is well above the sector average of 38, as overvalued. He recommends a wait-and-watch strategy, eyeing support levels at ₹6,750-6,594 for better entry. Stock trades near ₹7,449.